Immunovia, Inc., the American subsidiary of Immunovia AB (Nasdaq Stockholm: IMMNOV), announced that it has received final approval to begin patient testing for the IMMray® PanCan-d test – the first blood test on the market dedicated to the early detection of pancreatic cancer. Approximately 10-15% of all pancreatic cancer cases are attributed to a familial… Read More »IMMray® PanCan-d Test Receives Final Approval
The National Pancreas Foundation hosted its first Biotech Innovation Showcase at the annual American Pancreatic Association meeting. This Showcase highlighted 7 innovative companies in the pancreas space who are looking for partnerships to continue to grow and advance their companies and to help those fighting pancreatic disease. To review the presentations, please click here
The National Pancreas Foundation Announces the Designation of Twenty-Eight NPF Centers for the Treatment and Care of Pancreatic Cancer BETHESDA, MD – September 14, 2016 – The National Pancreas Foundation (NPF), a nonprofit organization that provides hope for those suffering from pancreatitis and pancreatic cancer, announces the designation of twenty-eight additional National Pancreas Foundation Centers for… Read More »The National Pancreas Foundation Announces the Designation of 28 Centers for Pancreatic Cancer
The National Pancreas Foundation Announces 2016 Research Grant Recipients NPF Awards 300,000 Dollars to Research Bethesda, MD – April 25, 2016 – The National Pancreas Foundation (NPF), a nonprofit organization dedicated to funding cutting edge research, advocating for new and better therapies, and providing support and education for those impacted by pancreatic disease, announced today that… Read More »2016 Research Grant Recipients
The National Pancreas Foundation Announces the Designation of Seven Additional NPF Centers for the Care and Treatment of Pancreatitis BETHESDA, MD – February 19, 2016 – The National Pancreas Foundation (NPF), a nonprofit organization that provides hope for those suffering from pancreatitis and pancreatic cancer, announces the designation of seven additional National Pancreas Foundation Centers.… Read More »Designation of Seven Additional NPF Centers
Here is a letter from a patient to her disease. Much of this will strike a chord with patients of pancreas disease. This young woman has familial chylomicronemia syndrome (FCS), which is a rare genetic disorder that causes the body to become unable to effectively clear lipid particles called chylomicrons. As a result, patients have… Read More »A Letter from a Patient to Her Disease
Boston Neighborhood Network (BNN) recently interviewed NPF co-founder Jane Holt to discuss the newly designated NPF Centers as well as progress being made in the treatment of pancreatic diseases.
The U.S. Food and Drug Administration today approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to treat patients with advanced (metastatic) pancreatic cancer who have been previously treated with gemcitabine-based chemotherapy. According to the National Cancer Institute, there will be 48,960 new cases of pancreatic cancer diagnosed in the U.S. in 2015,… Read More »FDA approves new treatment for advanced pancreatic cancer
National Pancreas Foundation to Honor Dr. Marty Makary with 2015 Nobility in Science Award BETHESDA, MD – Oct. 14, 2015 – The National Pancreas Foundation will honor Dr. Marty Makary of Johns Hopkins Medicine with the 2015 Nobility in Science award, which recognizes individuals who have made outstanding achievements in the areas of pancreatic research… Read More »2015 NPF Nobility in Science Recipient
The National Pancreas Foundation Announces the Designation of 30 NPF Centers for the Care and Treatment of Pancreatitis BETHESDA, MD – Sept. 1, 2015 – The National Pancreas Foundation (NPF), a nonprofit organization that provides hope for those suffering from pancreatitis and pancreatic cancer, announces the designation of 30 National Pancreas Foundation Centers. NPF Centers are… Read More »Announcing the Designation of 30 NPF Centers